Clinical Trial: Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS >= 50%

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596121) titled 'Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS >= 50%' on May 13.

Brief Summary: This prospective clinical study aims to evaluate and observe the efficacy and safety of Serplulimab Monotherapy in Elderly Patients with NSCLC and PD-L1 TPS >= 50% using a multicenter, single-arm, phase II design.

The study is planned to be conducted in Shaanxi Province, China, with an initial target enrollment of 60 patients. The study commenced in May 2026, and recruitment is expected to conclude around May 2026, with the trial anticipated to end by May 2027.

Assuming no occurrences such as withdrawal of informed consent by subj...